Naidoo, M.; Scott, C.L.; Lloyd, M.; McNally, O.; Rome, R.; Perera, S.; Zalcberg, J.R.
Barriers and Breakthroughs in Precision Oncology: A National Registry Study of BRCA Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR). Cancers 2025, 17, 2541.
https://doi.org/10.3390/cancers17152541
AMA Style
Naidoo M, Scott CL, Lloyd M, McNally O, Rome R, Perera S, Zalcberg JR.
Barriers and Breakthroughs in Precision Oncology: A National Registry Study of BRCA Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR). Cancers. 2025; 17(15):2541.
https://doi.org/10.3390/cancers17152541
Chicago/Turabian Style
Naidoo, Mahendra, Clare L Scott, Mike Lloyd, Orla McNally, Robert Rome, Sharnel Perera, and John R Zalcberg.
2025. "Barriers and Breakthroughs in Precision Oncology: A National Registry Study of BRCA Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR)" Cancers 17, no. 15: 2541.
https://doi.org/10.3390/cancers17152541
APA Style
Naidoo, M., Scott, C. L., Lloyd, M., McNally, O., Rome, R., Perera, S., & Zalcberg, J. R.
(2025). Barriers and Breakthroughs in Precision Oncology: A National Registry Study of BRCA Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR). Cancers, 17(15), 2541.
https://doi.org/10.3390/cancers17152541
